Stéphane Culine

Author PubWeight™ 3.23^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma.	N Engl J Med	2017	4.67